MedTrace Logo

Midazolam Effect in Children Undergoing Voiding Cystourethrogram (VCUG)

NCT00894465 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2016-12-09

Study results available
· View outcomes & findings →

Summary

The purpose of this research is to validate the common administration of oral midazolam to children prior to voiding cystourethrogram (VCUG) to see if this will significantly decrease children's anxiety and make the experience less traumatic.

Conditions

  • Vesicoureteral Reflux

Interventions

DRUG

midazolam

Children are randomized to receive oral midazolam .5 mg/kg prior to undergoing VCUG

DRUG

placebo

Children are randomized to receive a placebo prior to undergoing VCUG

Sponsors & Collaborators

  • Society of Pediatric Urology

    collaborator UNKNOWN

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Paul F Austin, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31
Primary Completion
2009-06-30
Completion
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00894465 on ClinicalTrials.gov